Dr. Steven Stice is the DW Brooks Distinguished Professor and Director of the Regenerative Bioscience Center at the University of Georgia, and the Co-Founder and Chief Scientific Officer of ArunA Biomedical. He talks about his early work cloning rabbits and reprogramming blastomeres. He also discusses using exosomes to treat neurological diseases, helping trainees move into industry, and preserving endangered species.
Dr. Agnete Kirkeby is an Associate Professor at the University of Copenhagen and a Group Leader at Lund University. The Kirkeby group studies the factors involved in human neural subtype specification in order to enable production of specific neurons for understanding and treating neurological diseases. They apply advanced human stem cells models to understand how hundreds of human neuronal subtypes are formed during embryo development. She talks about moving stem cell therapies for Parkinson’s disease from animal models to clinical trials, modeling neural tube development, and developing treatments for narcolepsy.
Dr. Aparna Bhaduri is an Assistant Professor of Biological Chemistry at the David Geffen School of Medicine at UCLA. Her lab studies how the human brain is created, with billions of cells spanning hundreds or thousands of cell types. They also explore how the cell building blocks of development can reappear later in life in brain cancers such as glioblastoma.
In June 2021, we attended the International Society for Stem Cell Research (ISSCR) virtual annual meeting, and recorded daily video episodes discussing highlights of the previous 24 hours. Here is the second of five special episodes from the meeting featuring Dr. Madeline Lancaster from the Medical Research Council (MRC) Laboratory of Molecular Biology, who was honored with the Dr. Susan Lim Award for Outstanding Young Investigator Lecture at the meeting.
Dr. Themasap Khan is the Vice President at Civilization Ventures, a venture capital firm that invests in genomics, diagnostics, digital health, AI, and personalized and regenerative medicine. He leads the firm’s scientific due diligence and academic outreach programs. Dr. Khan earned his in PhD in stem cell biology and regenerative medicine in Dr. Sergiu Pasca’s lab at Stanford, where his research focused on genome engineering, cerebellar organoid models, and live imaging to elucidate biological mechanisms underlying neuropsychiatric disorders.